Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features.

× No keyword cloud information.

9 in total

1. Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.

Authors: Miguel Torres-Martín; Victor Martinez-Glez; Carolina Peña-Granero; Luis Lassaletta; Alberto Isla; Jose M de Campos; Giovanny R Pinto; Rommel R Burbano; Bárbara Meléndez; Javier S Castresana; Juan A Rey
Journal: Clin Transl Oncol Date: 2012-10-02 Impact factor: 3.405

2. Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Authors: Sonam Dilwali; Martijn C Briët; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Michael P Platt; Konstantina M Stankovic
Journal: Mol Oncol Date: 2015-03-31 Impact factor: 6.603

3. Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells.

Authors: Vitor Y R Soares; Nadia A Atai; Takeshi Fujita; Sonam Dilwali; Sarada Sivaraman; Lukas D Landegger; Fred H Hochberg; Carlos A P C Oliveira; Fayez Bahmad; Xandra O Breakefield; Konstantina M Stankovic
Journal: Neuro Oncol Date: 2016-05-18 Impact factor: 12.300

4. Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size.

Authors: Sonam Dilwali; Andrew Lysaght; Daniel Roberts; Fred G Barker; Michael J McKenna; Konstantina M Stankovic
Journal: Otol Neurotol Date: 2013-06 Impact factor: 2.311

cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features.

1. Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.

2. Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

3. Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells.

4. Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size.

5. The Role of Tumor Necrosis Factor Alpha (TNFα)in Hearing Loss and Vestibular Schwannomas.

6. The molecular biology of vestibular schwannomas and its association with hearing loss: a review.

7. Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage.

8. Current Understanding of Hearing Loss in Sporadic Vestibular Schwannomas: A Systematic Review.

Review 9. Biomarkers in Vestibular Schwannoma-Associated Hearing Loss.